NFKB1 and Chronic colitis: Another in vitro study of chronic colitis model showed that earlier administration of citropten/ limettin reduced NF-κB and MAPK signaling pathway occurring in epithelium of intestine and triggered T cells (Lee et al. 2022b), in addition to reducing IL-6 in vascular inflammation model (Lee et al. 2022b).